These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 5753587)

  • 1. Effects of mitomycin c (NSC-26980) in 346 patients with advanced cancer. Eastern Clinical Drug Evaluation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):675-84. PubMed ID: 5753587
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitomycin (Mutamycin).
    Med Lett Drugs Ther; 1975 Jul; 17(15):62-3. PubMed ID: 50555
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with mitomycin C (NSC-26980).
    Whittington RM; Close HP
    Cancer Chemother Rep; 1970 Jun; 54(3):195-8. PubMed ID: 4334088
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase I study of 7-N-(p-hydroxyphenyl)-mitomycin C.
    Meguro S; Nagata T; Yokoyama K; Chinen T; Yamazaki H; Kobayashi T; Isogai Y; Ogawa M
    Invest New Drugs; 1984; 2(4):381-5. PubMed ID: 6511242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced gastrointestinal cancer with 5-fluorouracil and mitomycin C.
    Krauss S; Sonoda T; Solomon A
    Cancer; 1979 May; 43(5):1598-603. PubMed ID: 445355
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced chemosensitivity of cells from malignant effusions under condition of exposure to high temperature.
    Akiyoshi T; Wada T; Arinaga S; Koba F; Tsuji H
    Jpn J Surg; 1986 Sep; 16(5):323-9. PubMed ID: 3099042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent advanced studies on mitomycins, antitumor activity and mode of action].
    Taguchi T; Morimoto M
    Gan To Kagaku Ryoho; 1987 Jul; 14(7):2396-409. PubMed ID: 3111386
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of human gastrointestinal and breast cancer xenografts in nude mice with 5'-deoxy-5-fluorouridine and mitomycin C].
    Fujita F; Fujita M; Shimozuma K; Taguchi T
    Nihon Gan Chiryo Gakkai Shi; 1986 Aug; 21(7):1386-96. PubMed ID: 2946789
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of chlorambucil (NSC-3088) in 374 patients with advanced cancer. Eastern Clinical Drug Evualuation Program.
    Moore GE; Bross ID; Ausman R; Nadler S; Jones R; Slack N; Rimm AA
    Cancer Chemother Rep; 1968 Oct; 52(6):661-6. PubMed ID: 4895429
    [No Abstract]   [Full Text] [Related]  

  • 10. [Microangiopathic haemolytic anaemia as a complication of mitomycin C treatment (author's transl)].
    Tigges FJ; Bruntsch U; Groos G; Gallmeier WM
    Dtsch Med Wochenschr; 1982 Jan; 107(4):142-5. PubMed ID: 7056168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).
    Tucker WG; Talley RW; Lane M; Bonnet JD
    Cancer Chemother Rep; 1975; 59(2 Pt 1):425-7. PubMed ID: 1097101
    [No Abstract]   [Full Text] [Related]  

  • 12. Neurotoxicity from 5-fluorouracil (NSC-19893) administration reproduced by mitomycin C (NSC-26980).
    Nichols M; Bergevin PR; Vyas AC; Hamilin R
    Cancer Treat Rep; 1976 Mar; 60(3):293-4. PubMed ID: 1260786
    [No Abstract]   [Full Text] [Related]  

  • 13. [Phase I-II study of 7-N-(P-hydroxyphenyl)-mitomycin C (KW2083, M83)].
    Meguro S; Nagata T; Yokoyama K; Chinen T; Kobayashi T; Yamazaki H; Kuraishi Y; Ichiba ; Abe M; Isogai Y
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1818-22. PubMed ID: 6476844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phase II study of KW 2083 [7-N-(p-hydroxyphenyl)-mitomycin C] in patients with various cancers].
    Nishi I; Yokoyama T; Nakao I; Harashima S; Ohashi Y; Kanko T; Saito T
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2513-9. PubMed ID: 6508315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A clinical trial of a new mitomycin C derivative, KW-2083 (7-N-(p-hydroxyphenyl)-mitomycin C)].
    Takahashi K; Yokoyama M; Takahashi H; Wakui A
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1787-93. PubMed ID: 4037809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitomycin C in advanced cervical cancer.
    Tonusin A; Lorvidhaya V; Punpae P; Changwiwit W; Charoeniam V; Ployleumsang D; Issariyodom P
    J Med Assoc Thai; 1987 May; 70(5):275-9. PubMed ID: 2821141
    [No Abstract]   [Full Text] [Related]  

  • 17. [Gastrointestinal tumors. Prognostic factors and chemotherapy of today].
    Joss R; Goldhirsch A; Tschopp L; Brunner K
    Dtsch Med Wochenschr; 1981 Dec; 106(49):1664-9. PubMed ID: 7308009
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy with mitomycin C, 5-fluorouracil, and cytosine arabinoside in gastrointestinal cancer.
    De Jager RL; Magill GB; Golbey RB; Krakoff IH
    Cancer Treat Rep; 1976 Sep; 60(9):1373-5. PubMed ID: 1016970
    [No Abstract]   [Full Text] [Related]  

  • 19. Mitomycin C: experience in the United States, with emphasis on gastric cancer.
    Schein PS; Macdonald JS; Hoth D; Wooley PV
    Cancer Chemother Pharmacol; 1978; 1(2):73-5. PubMed ID: 750107
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical study of mitomycin C (NSC-26980) in colorectal cancer.
    Ansfield FJ
    Cancer Chemother Rep; 1969 Oct; 53(5):287-9. PubMed ID: 5377615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.